Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that targeting both hair follicles and surrounding tissue offers a safe and significantly beneficial improvement in androgenetic alopecia symptoms, with advanced dermocosmetics playing a crucial role alongside traditional pharmacological interventions in long-term management.

This study suggests that targeting specific immune pathways, such as IL-12/23 and Th2 cytokines, may offer new treatment options for alopecia areata, a T-cell-mediated disease without current mechanism-specific therapies.

This study found that patients with androgenetic alopecia experienced higher treatment efficacy when using a combination of antler-based products "Pantogematogen" and "Chudopan" compared to other methods.

In this study, a woman's hair loss and physical condition reportedly improved with pharmacopuncture and needle-embedding therapy, but further research is suggested to validate these findings.

This case study found that pharmacopuncture and needle-embedding therapy improved hair loss and physical condition in a woman with androgenetic alopecia, but further clinical studies are needed.

This study found that total glucosides of paeony (TGP) reduced hair loss and inflammation in alopecia areata mice by inhibiting cellular pyroptosis.

This study found that ATP-sensitive potassium channels may play a role in chloroquine-induced itching in mice, as channel openers reduced scratching behavior while a blocker reversed these effects.

This source reports limited evidence supporting the use of certain diets, supplements, essential oils, and psychosocial interventions for patients with androgenetic alopecia seeking complementary therapies.

This abstract highlights that alopecia treatment requires moving beyond outdated methods to a sophisticated approach that considers the complex interplay between genetic susceptibility and immune response in different types of hair loss. Results are not reported.

This study, involving a retrospective analysis of 24 patients in France, found that paradoxical psoriasiform alopecic reactions on the scalp associated with TNFα-targeted therapies for inflammatory bowel disease are rare yet non-scarring, with all patients achieving complete hair regrowth within two months after treatment adjustments.

A combination of dietary changes, lifestyle adjustments, acupuncture, and herbal treatment improved hair growth by 70%.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

The author believes that giving medical conditions official names can sometimes overwhelm or scare patients.

This meta-analysis found that plum-blossom needling, as an add-on therapy, provided moderate beneficial effects on hair regrowth in alopecia areata patients compared to conventional treatment alone.

This study investigated the effectiveness of a botanical formulation, Zauberӧl®, on testosterone-induced alopecia in Wistar rats, focusing on ingredients such as Arnica montana and Hibiscus Rosa sinensis. Results are not reported in the abstract.

This source reviews various alternative therapies for vitiligo, such as khellin, 5-fluorouracil, Ginkgo biloba, and more, noting that further research is needed to confirm their effectiveness and safety.

This study found that trichodynia is associated with both peripheral and central sensitization, potentially linked to hair cycle abnormalities and chronic pain through proinflammatory agents.

This case report details a 19-year-old female with autoimmune hair loss successfully managed using an integrated Ayurvedic approach, achieving complete hair regrowth and symptom resolution within two months, suggesting potential efficacy for autoimmune conditions warranting further study.

This case series found that combining ablative fractional resurfacing and acoustic pressure ultrasound with triamcinolone treatment led to complete recovery in patients with areata alopecia.

In a mouse model study, transcutaneous auricular vagus nerve stimulation (taVNS) significantly reduced depigmentation in vitiligo, potentially through mechanisms that regulate oxidative stress and inflammation, indicating taVNS's promise as a therapeutic approach for this skin disorder.

This study developed a physician-guided algorithm to manage cutaneous adverse events from hormonal therapy in cancer patients, aiming to reduce treatment interruptions and enhance quality of life.

This review examines the psychological effects of chronic hair diseases, noting significant impacts on self-confidence and quality of life, particularly in women with androgenetic alopecia and patients undergoing chemotherapy.

This study found that intralesional corticosteroids remain the preferred treatment for alopecia areata with limited involvement, while platelet-rich plasma showed promise, particularly in children and extensive cases.

This abstract reviews the symptom of trichodynia, a painful scalp sensation linked to hair loss, and highlights its potential connection to inflammation but reports no new research findings.

This study found that patients with alopecia areata showing low treatment burden responded better to baricitinib compared to those with higher previous systemic treatment exposure.

This study suggests that long-term treatment with the contact sensitizer SADBE in mice may reduce leucocyte traffic in alopecia areata through impaired leucocyte extravasation.

This study reports that elderly men with baldness and comorbid conditions experienced persistent scalp erosions following topical treatment with imiquimod or diclofenac, suggesting alternative therapies should be considered for this group.

The researchers highlighted the need for empathetic and caring healthcare professionals for alopecia patients, recommending enhanced training for general practitioners and improved coordination between primary and secondary care pathways.

This study conducted a narrative literature review on androgenetic alopecia, highlighting the clinical diagnosis and management strategies, including minoxidil and 5-alpha-reductase inhibitors for men, and antiandrogens for women, along with the use of aesthetic procedures like microneedling as complementary therapies.